|
1
|
Marcu LG and Yeoh E: A review of risk
factors and genetic alterations in head and neck carcinogenesis and
implications for current and future approaches to treatment. J
Cancer Res Clin Oncol. 135:1303–1314. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen C, Méndez E, Houck J, Fan W,
Lohavanichbutr P, Doody D, Yueh B, Futran ND, Upton M, Farwell DG,
et al: Gene expression profiling identifies genes predictive of
oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev.
17:2152–2162. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Todd R, McBride J, Tsuji T, Donoff RB,
Nagai M, Chou MY, Chiang T and Wong DT: Deleted in oral cancer-1
(doc-1), a novel oral tumor suppressor gene. FASEB J. 9:1362–1370.
1995.PubMed/NCBI
|
|
6
|
Tsuji T, Duh FM, Latif F, Popescu NC,
Zimonjic DB, McBride J, Matsuo K, Ohyama H, Todd R, Nagata E, et
al: Cloning, mapping, expression, function, and mutation analyses
of the human ortholog of the hamster putative tumor suppressor gene
Doc-1. J Biol Chem. 273:6704–6709. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shintani S, Mihara M, Terakado N, Nakahara
Y, Matsumura T, Kohno Y, Ohyama H, McBride J, Kent R, Todd R, et
al: Reduction of p12DOC-1 expression is a negative
prognostic indicator in patients with surgically resected oral
squamous cell carcinoma. Clin Cancer Res. 7:2776–2782.
2001.PubMed/NCBI
|
|
8
|
Kohno Y, Patel V, Kim Y, Tsuji T, Chin BR,
Sun M, Bruce Donoff R, Kent R, Wong D and Todd R: Apoptosis,
proliferation and p12(doc-1) profiles in normal, dysplastic and
malignant squamous epithelium of the Syrian hamster cheek pouch
model. Oral Oncol. 38:274–280. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matsuo K, Shintani S, Tsuji T, Nagata E,
Lerman M, McBride J, Nakahara Y, Ohyama H, Todd R and Wong DT:
p12(DOC-1), a growth suppressor, associates with DNA polymerase
alpha/primase. FASEB J. 14:1318–1324. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Buajeeb W, Zhang X, Ohyama H, Han D,
Surarit R, Kim Y and Wong DT: Interaction of the CDK2-associated
protein-1, p12(DOC-1/CDK2AP1), with its homolog, p14(DOC-1R).
Biochem Biophys Res Commun. 315:998–1003. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang SW, Hao LY and Zhang TH: Prediction
of protein-protein interaction with pairwise kernel support vector
machine. Int J Mol Sci. 15:3220–3233. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hue M, Riffle M, Vert JP and Noble WS:
Large-scale prediction of protein-protein interactions from
structures. BMC Bioinformatics. 11:1442010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Craig RA and Liao L: Improving protein
protein interaction prediction based on phylogenetic information
using a least-squares support vector machine. Ann NY Acad Sci.
1115:154–167. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen W, Zhang SW, Cheng YM and Pan Q:
Prediction of protein-protein interaction types using the decision
templates based on multiple classier fusion. Math Comput Model.
52:2075–2084. 2010. View Article : Google Scholar
|
|
15
|
Todd R, Hinds PW, Munger K, Rustgi AK,
Opitz OG, Suliman Y and Wong DT: Cell cycle dysregulation in oral
cancer. Crit Rev Oral Biol Med. 13:51–61. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shintani S, Ohyama H, Zhang X, McBride J,
Matsuo K, Tsuji T, Hu MG, Hu G, Kohno Y, Lerman M, et al:
p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein.
Mol Cell Biol. 20:6300–6307. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou W, Guan X, Wang L, Liao Y and Huang
J: p12(CDK2-AP1) inhibits breast cancer cell proliferation and in
vivo tumor growth. J Cancer Res Clin Oncol. 138:2085–2093. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choi MG, Sohn TS, Park SB, Paik YH, Noh
JH, Kim KM, Park CK and Kim S: Decreased expression of p12 is
associated with more advanced tumor invasion in human gastric
cancer tissues. Eur Surg Res. 42:223–229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hiyoshi Y, Watanabe M, Hirashima K,
Karashima R, Sato N, Imamura Y, Nagai Y, Yoshida N, Toyama E,
Hayashi N, et al: p12CDK2-AP1 is associated with tumor
progression and a poor prognosis in esophageal squamous cell
carcinoma. Oncol Rep. 22:35–39. 2009.PubMed/NCBI
|
|
20
|
Sun M, Zheng J, Xue H, Jiang Y, Li C, Li
J, Jin W, Shen M, Yang X and Ni Q: Silencing P12CDK2AP1
with a lentivirus promotes HaCaT cell proliferation. Mol Med Rep.
7:471–475. 2013.
|
|
21
|
Zheng J, Xue H, Wang T, Jiang Y, Liu B, Li
J, Liu Y, Wang W, Zhang B and Sun M: miR-21 downregulates the tumor
suppressor P12 CDK2AP1 and stimulates cell proliferation and
invasion. J Cell Biochem. 112:872–880. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu L, Yang X, Ni Q, Xiao Z, Zhao Y, Han
J, Sun M and Chen B: Interaction between p12CDK2AP1 and
a novel unnamed protein product inhibits cell proliferation by
regulating the cell cycle. Mol Med Rep. 9:156–162. 2014.
|
|
23
|
Dong JT, Lamb PW, Rinker-Schaeffer CW,
Vukanovic J, Ichikawa T, Isaacs JT and Barrett JC: KAI1, a
metastasis suppressor gene for prostate cancer on human chromosome
11p11.2. Science. 268:884–886. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tang Y, Cheng Y, Martinka M, Ong CJ and Li
G: Prognostic significance of KAI1/CD82 in human melanoma and its
role in cell migration and invasion through the regulation of ING4.
Carcinogenesis. 35:86–95. 2014. View Article : Google Scholar
|
|
25
|
Rowe A and Jackson P: Expression of
KITENIN, a KAI1/CD82 binding protein and metastasis enhancer, in
bladder cancer cell lines: Relationship to KAI1/CD82 levels and
invasive behaviour. Oncol Rep. 16:1267–1272. 2006.PubMed/NCBI
|
|
26
|
Malik FA, Sanders AJ, Kayani MA and Jiang
WG: Effect of expressional alteration of KAI1 on breast cancer cell
growth, adhesion, migration and invasion. Cancer Genomics
Proteomics. 6:205–213. 2009.PubMed/NCBI
|
|
27
|
Pal'tseva EM, Samofalova OIu, Gorbacheva
IuV and Tsar'kov PV: Expression of some biomarkers in primary colon
adenocarcinomas and their lymph node metastases. Arkh Patol.
74:12–18. 2012.In Russian. PubMed/NCBI
|
|
28
|
Friess H, Guo XZ, Tempia-Caliera AA,
Fukuda A, Martignoni ME, Zimmermann A, Korc M and Büchler MW:
Differential expression of metastasis-associated genes in papilla
of vater and pancreatic cancer correlates with disease stage. J
Clin Oncol. 19:2422–2432. 2001.PubMed/NCBI
|
|
29
|
Choi UJ, Jee BK, Lim Y and Lee KH:
KAI1/CD82 decreases Rac1 expression and cell proliferation through
PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells. Cell Biochem
Funct. 27:40–47. 2009. View Article : Google Scholar
|
|
30
|
Shiwu WU, Lan Y, Wenqing S, Lei Z and
Yisheng T: Expression and clinical significance of CD82/KAI1 and
E-cadherin in non-small cell lung cancer. Arch Iran Med.
15:707–712. 2012.PubMed/NCBI
|
|
31
|
Liu FS, Dong JT, Chen JT, Hsieh YT, Ho ES,
Hung MJ, Lu CH and Chiou LC: KAI1 metastasis suppressor protein is
down-regulated during the progression of human endometrial cancer.
Clin Cancer Res. 9:1393–1398. 2003.PubMed/NCBI
|
|
32
|
Miyazaki T, Kato H, Shitara Y, Yoshikawa
M, Tajima K, Masuda N, Shouji H, Tsukada K, Nakajima T and Kuwano
H: Mutation and expression of the metastasis suppressor gene KAI1
in esophageal squamous cell carcinoma. Cancer. 89:955–962. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Imai Y, Sasaki T, Shinagawa Y, Akimoto K
and Fujibayashi T: Expression of metastasis suppressor gene
(KAI1/CD82) in oral squamous cell carcinoma and its
clinico-pathological significance. Oral Oncol. 38:557–561. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Farhadieh RD, Smee R, Ow K, Yang JL,
Russell PJ, Crouch R, Jackson P and Jacobson IV: Down-regulation of
KAI1/CD82 protein expression in oral cancer correlates with reduced
disease free survival and overall patient survival. Cancer Lett.
213:91–98. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kawasaki G, Yoshitomi I, Yanamoto S,
Yamada S, Mizuno A and Umeda M: Expression of thymidylate synthase
and dihydropyrimidine dehydrogenase in primary oral squamous cell
carcinoma and corresponding metastases in cervical lymph nodes:
Association with the metastasis suppressor CD82. Anticancer Res.
31:3521–3526. 2011.PubMed/NCBI
|
|
36
|
Abe M, Sugiura T, Takahashi M, Ishii K,
Shimoda M and Shirasuna K: A novel function of CD82/KAI-1 on
E-cadherin-mediated homophilic cellular adhesion of cancer cells.
Cancer Lett. 266:163–170. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Takahashi M, Sugiura T, Abe M, Ishii K and
Shirasuna K: Regulation of c-Met signaling by the tetraspanin
KAI-1/CD82 affects cancer cell migration. Int J Cancer.
121:1919–1929. 2007. View Article : Google Scholar : PubMed/NCBI
|
